USE OF A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PB-PK) NICOTINE-COTININE MODEL TO ASSESS THE INFLUENCE OF NICOTINE ON THE DISTRIBUTION OF COTININE IN MAN

被引：0
|
作者：
ROBINSON, DE [1 ]
BALTER, NJ [1 ]
SCHWARTZ, SL [1 ]
机构：
[1] GEORGETOWN UNIV, SCH MED, WASHINGTON, DC 20007 USA
来源：
FASEB JOURNAL | 1991年 / 5卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1568 / A1568
页数：1
相关论文
共 16 条
  • [1] A PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL FOR NICOTINE AND COTININE IN MAN
    ROBINSON, DE
    BALTER, NJ
    SCHWARTZ, SL
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1992, 20 (06): : 591 - 609
  • [2] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PB-PK) MODEL FOR DESETHYLAMIODARONE
    HOU, ZY
    BALTER, NJ
    WOOSLEY, RL
    SCHWARTZ, SL
    CIRCULATION, 1990, 82 (04) : 196 - 196
  • [3] MICROCOMPUTER PROGRAMS FOR PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PB-PK) MODELING
    DONG, MH
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 1994, 45 (03) : 213 - 221
  • [4] Physiologically Based Pharmacokinetic Modelling for Nicotine and Cotinine Clearance in Pregnant Women
    Amice, Basile
    Ho, Harvey
    Zhang, En
    Bullen, Chris
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [5] A physiologically-based pharmacokinetic (PB-PK) model for ethylene dibromide: relevance of extrahepatic metabolism
    Hissink, AM
    Wormhoudt, LW
    Sherratt, PJ
    Hayes, JD
    Commandeur, JNM
    Vermeulen, NPE
    van Bladeren, PJ
    FOOD AND CHEMICAL TOXICOLOGY, 2000, 38 (08) : 707 - 716
  • [6] VALIDATION OF A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PB-PK) MODEL USED TO SIMULATE ABSORBED MALATHION DOSES IN HUMANS
    DONG, MH
    THONGSINTHUSAK, T
    ROSS, JH
    KRIEGER, RI
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 65 - AGRO
  • [7] SIMULATIONS OF SHORT-TERM-IV AMIODARONE DOSING WITH A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PB-PK) MODEL
    HOU, ZY
    BALTER, NJ
    CHEN, CY
    WOOSLEY, RL
    SCHWARTZ, SL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 174 - 174
  • [8] INCORPORATION OF INVITRO ENZYME DATA INTO THE PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PB-PK) MODEL FOR METHYLENE-CHLORIDE - IMPLICATIONS FOR RISK ASSESSMENT
    REITZ, RH
    MENDRALA, AL
    PARK, CN
    ANDERSEN, ME
    GUENGERICH, FP
    TOXICOLOGY LETTERS, 1988, 43 (1-3) : 97 - 116
  • [9] Use of a physiologically-based pharmacokinetic model to explore the potential disparity in nicotine disposition between adult and adolescent nonhuman primates
    Yang, Xiaoxia
    Naylor, Jennifer
    Matazel, Katelin
    Goodwin, Amy
    Jacob, Cristina C.
    Bryant, Matthew
    Loukotkova, Lucie
    da Costa, Goncalo Gamboa
    Chemerynski, Susan
    Deng-Bryant, Ying
    Reissig, Chad
    Jackson, Kia
    Fisher, Jeffrey
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2020, 386
  • [10] USE OF A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR ANALYSIS OF ANTIBIOTIC DISTRIBUTION IN TISSUE
    MANUILOV, KK
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1992, 30 (11) : 548 - 549
12